Phase I, Drug-drug Interaction Study of the Inhibition Potential of KL1333 in Healthy Subjects
Condition:   Mitochondrial Disease Interventions:   Drug: KL1333;   Drug: Flurbiprofen;   Drug: Dextromethorphan;   Drug: Bupropion;   Drug: Midazolam injection;   Drug: Omeprazole;   Drug: Caffeine;   Drug: Repaglinide Sponsor:   Abliva AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2020 Category: Research Source Type: clinical trials

Drug-drug Interaction Study of KL1333 in Healthy Subjects
Condition:   Mitochondrial Disease Interventions:   Drug: KL1333;   Drug: Flurbiprofen;   Drug: Dextromethorphan;   Drug: Bupropion;   Drug: Midazolam injection;   Drug: Omeprazole;   Drug: Caffeine;   Drug: Repaglinide Sponsor:   Abliva AB Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 25, 2020 Category: Research Source Type: clinical trials